 |
| |
Ceapro Inc. (Ceapro) is a Canada-based biotechnology company. The primary activities of the Company relate to the development and commercialization of natural and organic products for medical, cosmetic, and animal health industries using technology and natural, renewable resources. The products of the Company include a commercial line of natural and organic active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, which are marketed to the personal care, cosmetic, and nutraceutical industries, and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner, which are manufactured and marketed to veterinarians in Japan and Asia, through agreements with Daisen Sangyo Co. Ltd., and in Canada by Aventix Animal Health. The Company's subsidiaries include Ceapro Technology Inc., Ceapro Veterinary Products Inc. and Ceapro Active Ingredients Inc.
Ceapro Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Ceapro Inc. (Ceapro) is a Canadian growth-stage biotechnology company. It is principally engaged in the research, production and commercialization of natural and organic products for medical, cosmetic, and animal health. The company operates along with its five subsidiaries. It uses technology and natural, renewable resources for its products. Ceapro is principally focused on developing a wide range of active ingredients and formulations to enhance the human and animal health. The company operates through three product categories; namely, active ingredient, veterinary therapeutic products and diabetes screening.
The Ceapro Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Ceapro Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile: http://www.companiesandmarkets.com/r.ashx?id=1SB7WJW19166476
|
—
